3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow HBV: new trials by email Literature Review of HBV trials Research Report on HBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B Antroquinonol, placebo - HBV | Phase 2 | Completed | Golden Biotechnology Corporation | 60 | 2018-02-12 | 2026-10-19 |
| A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses Engerix B, Fendrix - HIV, Communicable Diseases | Phase 2 / Phase 3 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 13 | 2015-07-23 | 2022-09-29 |
| Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials Entecavir, Lamivudine - Hepatitis B Virus, HBV | Phase 2 | Completed | Bristol-Myers Squibb | 1053 | 2001-01-01 | 2012-08-23 |
Hepatitis B (2) · Communicable Diseases (1)
Blood-Borne Infections (2) · DNA Virus Infections (2) · Digestive System Diseases (2) · Hepadnaviridae Infections (2) · Hepatitis (2) · Hepatitis, Viral, Human (2) · Infections (2) · Liver Diseases (2) · Virus Diseases (2) · Communicable Diseases (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Engerix-B (1) · Fendrix (1) · Lamivudine (1) · antroquinonol (1) · entecavir (1)
Bristol-Myers Squibb (1) · Golden Biotechnology Corporation (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1)
Taiwan (1) · United Kingdom (1)
Cheng-Chung Wei, MD (1) · Ching-Pin Lin, MD (1)